Prognostic comparison of COVID-19 outpatients and inpatients treated with Remdesivr: A retrospective cohort study.
PloS one(2022)
Abstract
Based on the results of this study, the outcome, signs, and symptoms of inpatient and outpatient Remdesivir treatment groups did not differ significantly. Hence in COVID-19 surges where we have limitations in admitting patients, outpatient Remdesivir treatment for those without any underlying diseases can be a proper management method.
MoreTranslated text
Key words
remdesivr,prognostic comparison,inpatients,cohort study
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined